Luteolinidin protects the postischemic heart through CD38 inhibition with preservation of NAD(P)(H)

Journal of Pharmacology and Experimental Therapeutics

Volumn 361, Issue 1, 2017, Pages 99-108

  Boslett, James ^a   Hemann, Craig ^a   Zhao, Yong Juan ^b   Lee, Hon Cheung ^b   Zweier, Jay L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; LUTEOLINIDIN; NITRITE REDUCTASE [NAD(P)H]; PROTECTIVE AGENT; UNCLASSIFIED DRUG; ADP RIBOSYL CYCLASE/CYCLIC ADP RIBOSE HYDROLASE 1; ANTHOCYANIN; CARDIOTONIC AGENT; CD38 PROTEIN, HUMAN; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; HUMAN; METABOLISM; SPRAGUE DAWLEY RAT;

ADP-RIBOSYL CYCLASE 1; ANIMALS; ANTHOCYANINS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MYOCARDIAL ISCHEMIA; NADP; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 85017680823     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.116.239459     Document Type: Article

References (63)

1. Aliev MK, Dos Santos P, Hoerter JA, Soboll S, Tikhonov AN, and Saks VA (2002) Water content and its intracellular distribution in intact and saline perfused rat hearts revisited. Cardiovasc Res 53:48-58.
2. Amorini AM, Lazzarino G, Galvano F, Fazzina G, Tavazzi B, and Galvano G (2003) Cyanidin-3-O-beta-glucopyranoside protects myocardium and erythrocytes from oxygen radical-mediated damages. Free Radic Res 37:453-460.
3. Aneja R, Hake PW, Burroughs TJ, Denenberg AG, Wong HR, and Zingarelli B (2004) Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med 10:55-62.
4. Awika JM, Rooney LW, and Waniska RD (2004) Properties of 3-deoxyanthocyanins from sorghum. J Agric Food Chem 52:4388-4394.
5. Bailey SW and Ayling JE (2009) The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 106:15424-15429.
6. Becherer JD, Boros EE, Carpenter TY, Cowan DJ, Deaton DN, Haffner CD, Jeune MR, Kaldor IW, Poole JC, Preugschat F, et al. (2015) Discovery of 4-amino-8-quinoline carboxamides as novel, submicromolar inhibitors of NAD-hydrolyzing enzyme CD38. J Med Chem 58:7021-7056.
7. Blacher E, Ben Baruch B, Levy A, Geva N, Green KD, Garneau-Tsodikova S, Fridman M, and Stein R (2015) Inhibition of glioma progression by a newly discovered CD38 inhibitor. Int J Cancer 136:1422-1433.
8. Boesten DM, von Ungern-Sternberg SN, den Hartog GJ, and Bast A (2015) Protective pleiotropic effect of flavonoids on NAD1 levels in endothelial cells exposed to high glucose. Oxid Med Cell Longev 2015:894597.
9. Chang WT, Shao ZH, Yin JJ, Mehendale S, Wang CZ, Qin Y, Li J, Chen WJ, Chien CT, Becker LB, et al. (2007) Comparative effects of flavonoids on oxidant scavenging and ischemia-reperfusion injury in cardiomyocytes. Eur J Pharmacol 566: 58-66.
10. Chen CA, Lin CH, Druhan LJ, Wang TY, Chen YR, and Zweier JL (2011) Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating eNOS function and coupling. J Biol Chem 286: 29098-29107.
11. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, and Zweier JL (2010) S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468:1115-1118.
12. Crane RK and Sols A (1954) The non-competitive inhibition of brain hexokinase by glucose-6-phosphate and related compounds. J Biol Chem 210:597-606.
13. Cunnington C, Van Assche T, Shirodaria C, Kylintireas I, Lindsay AC, Lee JM, Antoniades C, Margaritis M, Lee R, Cerrato R, et al. (2012) Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 125:1356-1366.
14. De Pascali F, Hemann C, Samons K, Chen CA, and Zweier JL (2014) Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry 53:3679-3688.
15. Deanfield JE, Halcox JP, and Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115:1285-1295.
16. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, and Zweier JL (2007) Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA 104: 15081-15086.
17. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, Kwak HK, Milbury P, Paul SM, Blumberg J, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23:197-204.
18. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O'Neil L, White TA, Sinclair DA, and Chini EN (2013) Flavonoid apigenin is an inhibitor of the NAD1 ase CD38: implications for cellular NAD1 metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes 62:1084-1093.
19. Fantinelli JC, Schinella G, Cingolani HE, and Mosca SM (2005) Effects of different fractions of a red wine non-alcoholic extract on ischemia-reperfusion injury. Life Sci 76:2721-2733.
20. Ferrari R, Alfieri O, Curello S, Ceconi C, Cargnoni A, Marzollo P, Pardini A, Caradonna E, and Visioli O (1990) Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81:201-211.
21. Gao L, Pung YF, Zhang J, Chen P, Wang T, Li M, Meza M, Toro L, and Cai H (2009) Sepiapterin reductase regulation of endothelial tetrahydrobiopterin and nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 297:H331-H339.
22. Geraets L, Moonen HJ, Brauers K, Wouters EF, Bast A, and Hageman GJ (2007) Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr 137:2190-2195.
23. Giraldez RR, Panda A, and Zweier JL (2000) Endothelial dysfunction does not require loss of endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 278: H2020-H2027.
24. Grassi D, Desideri G, Di Giosia P, De Feo M, Fellini E, Cheli P, Ferri L, and Ferri C (2013) Tea, flavonoids, and cardiovascular health: endothelial protection. Am J Clin Nutr 98(Suppl):1660S-1666S.
25. Gul R, Park DR, Shawl AI, Im SY, Nam TS, Lee SH, Ko JK, Jang KY, Kim D, and Kim UH (2016) Nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP-ribose (cADPR) mediate Ca21 signaling in cardiac hypertrophy induced by b-adrenergic stimulation. PLoS One 11:e0149125.
26. Hadi HA, Carr CS, and Al Suwaidi J (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1:183-198.
27. Haffner CD, Becherer JD, Boros EE, Cadilla R, Carpenter T, Cowan D, Deaton DN, Guo Y, Harrington W, Henke BR, et al. (2015) Discovery, synthesis, and biological evaluation of thiazoloquin(az)olin(on)es as potent CD38 inhibitors. J Med Chem 58: 3548-3571.
28. Hausenloy DJ and Yellon DM (2013) Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 123:92-100.
29. Hertog MG, Feskens EJ, Hollman PC, Katan MB, and Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-1011.
30. Hirai M, Hotta Y, Ishikawa N, Wakida Y, Fukuzawa Y, Isobe F, Nakano A, Chiba T, and Kawamura N (2007) Protective effects of EGCg or GCg, a green tea catechin epimer, against postischemic myocardial dysfunction in guinea-pig hearts. Life Sci 80:1020-1032.
31. Hodgson JM (2006) Effects of tea and tea flavonoids on endothelial function and blood pressure: a brief review. Clin Exp Pharmacol Physiol 33:838-841.
32. Hung LM, Su MJ, and Chen JK (2004) Resveratrol protects myocardial ischemiareperfusion injury through both NO-dependent and NO-independent mechanisms. Free Radic Biol Med 36:774-781.
33. Ikizler M, Erkasap N, Dernek S, Kural T, and Kaygisiz Z (2007) Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment. Anadolu Kardiyol Derg 7:404-410.
34. Keli SO, Hertog MG, Feskens EJ, and Kromhout D (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156: 637-642.
35. Kellenberger E, Kuhn I, Schuber F, and Muller-Steffner H (2011) Flavonoids as inhibitors of human CD38. Bioorg Med Chem Lett 21:3939-3942.
36. Klaidman LK, Leung AC, and Adams JD, Jr (1995) High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. Anal Biochem 228:312-317.
37. Lee HC (2012) Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization. J Biol Chem 287:31633-31640.
38. Li H, Hemann C, Abdelghany TM, El-Mahdy MA, and Zweier JL (2012) Characterization of the mechanism and magnitude of cytoglobin-mediated nitrite reduction and nitric oxide generation under anaerobic conditions. J Biol Chem287: 36623-36633.
39. Liaudet L, Yang Z, Al-Affar EB, and Szabó C (2001) Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med 7: 406-417.
40. Loukogeorgakis SP, van den Berg MJ, Sofat R, Nitsch D, Charakida M, Haiyee B, de Groot E, MacAllister RJ, Kuijpers TW, and Deanfield JE (2010) Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 121: 2310-2316.
41. Maeda J, Roybal EJ, Brents CA, Uesaka M, Aizawa Y, and Kato TA (2014) Natural and glucosyl flavonoids inhibit poly(ADP-ribose) polymerase activity and induce synthetic lethality in BRCA mutant cells. Oncol Rep 31:551-556.
42. Michaelis L, Menten ML, Johnson KA, and Goody RS (2011) The original Michaelis constant: translation of the 1913 Michaelis-Menten paper. Biochemistry 50: 8264-8269.
43. Moreau C, Liu Q, Graeff R, Wagner GK, Thomas MP, Swarbrick JM, Shuto S, Lee HC, Hao Q, and Potter BV (2013) CD38 structure-based inhibitor design using the N1-cyclic inosine 59-diphosphate ribose template. PLoS One 8:e66247.
44. Munshi CB, Fryxell KB, Lee HC, and Branton WD (1997) Large-scale production of human CD38 in yeast by fermentation. Methods Enzymol 280:318-330.
45. Necas J, Bartosíková L, Florian T, Klusáková J, Suchý V, Naggar EM, Janostíková E, Bartosík T, and Lisková M (2006) [Protective effects of the flavonoids osajin and pomiferin on heart ischemia-reperfusion]. Ceska Slov Farm 55:168-174.
46. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, and van Leeuwen PA (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74:418-425.
47. Palmer RM, Ferrige AG, and Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
48. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, and Osuna A (2009) Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 61:67-75.
49. Pieper AA, Walles T, Wei G, Clements EE, Verma A, Snyder SH, and Zweier JL (2000) Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol Med 6:271-282.
50. Reyes LA, Boslett J, Varadharaj S, De Pascali F, Hemann C, Druhan LJ, Ambrosio G, El-Mahdy M, and Zweier JL (2015) Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart. Proc Natl Acad Sci USA 112:11648-11653.
51. Scarabelli TM, Mariotto S, Abdel-Azeim S, Shoji K, Darra E, Stephanou A, Chen-Scarabelli C, Marechal JD, Knight R, Ciampa A, et al. (2009) Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/ reperfusion-induced injury. FEBS Lett 583:531-541.
52. Szabó G, Liaudet L, Hagl S, and Szabó C (2004) Poly(ADP-ribose) polymerase activation in the reperfused myocardium. Cardiovasc Res 61:471-480.
53. Toufektsian MC, de Lorgeril M, Nagy N, Salen P, Donati MB, Giordano L, Mock HP, Peterek S, Matros A, Petroni K, et al. (2008) Chronic dietary intake of plantderived anthocyanins protects the rat heart against ischemia-reperfusion injury. J Nutr 138:747-752.
54. Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81 (Suppl):292S-297S.
55. Vu CQ, Lu PJ, Chen CS, and Jacobson MK (1996) 29-Phospho-cyclic ADP-ribose, a calcium-mobilizing agent derived from NADP. J Biol Chem 271:4747-4754.
56. Wang S, Zhu W, Wang X, Li J, Zhang K, Zhang L, Zhao YJ, Lee HC, and Zhang L (2014) Design, synthesis and SAR studies of NAD analogues as potent inhibitors towards CD38 NADase. Molecules 19:15754-15767.
57. Williamson G and Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81 (Suppl): 243S-255S.
58. Winkler BS, DeSantis N, and Solomon F (1986) Multiple NADPH-producing pathways control glutathione (GSH) content in retina. Exp Eye Res 43: 829-847.
59. Yamazaki KG, Romero-Perez D, Barraza-Hidalgo M, Cruz M, Rivas M, Cortez-Gomez B, Ceballos G, and Villarreal F (2008) Short-and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 295: H761-H767.
60. Zimmerman AN and Hülsmann WC (1966) Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211: 646-647.
61. Zweier JL, Kuppusamy P, and Lutty GA (1988) Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 85:4046-4050.
62. Zweier JL, Kuppusamy P, Williams R, Rayburn BK, Smith D, Weisfeldt ML, and Flaherty JT (1989) Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 264:18890-18895.
63. Zweier JL and Talukder MA (2006) The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70:181-190.